Monopar Therapeutics Inc.
NASDAQMonopar Therapeutics heads into its August earnings window with a stock that has more than doubled off its lows, shorts quietly trimming exposure, and the Street nudging targets higher — yet the borrow market remains tight enough to keep this a charged setup. The most striking feature of the past month is the rally itself. MNPR has gained 68% in a month and 14% in the past week…
Snapshot as of 12 Aug 2026
Monopar Therapeutics heads into its August earnings window with a stock that has more than doubled off its lows, shorts quietly trimming exposure, and the Street nudging targets higher — yet the borrow market remains…
Monopar Therapeutics has surged 30% in a single week — yet short interest remains near 24% of float and the lending pool is close to fully squeezed, making the tension between bulls and bears unusually charged. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MNPR — free to start on ORTEX.
Sign up for free →Open MNPR on ORTEX